PubMed

Study on the effects of nitrilotriproprionic acid and 4,5-dihydroxy-1,3-benzene disulphonate on the fractionation of beryllium in human serum using graphite furnace atomic absorption spectrometry.

Stephan CH, Fournier M, Brousseau P, Sauvé S.

Chem Cent J. 2008 May 14;2:10.PMID: 18479524 [PubMed]Free PMC ArticleFree textRelated citations

Use of proliferation tests to evaluate the effects of complexing agents on beryllium toxicity.

Stephan CH, Sauvé S, Fournier M, Brousseau P.

J Appl Toxicol. 2009 Jan;29(1):27-35.PMID: 18785683 [PubMed - indexed for MEDLINE]Related citations

Graphite furnace atomic absorption spectrometry as a routine method for the quantification of beryllium in blood and serum.

Stephan CH, Fournier M, Brousseau P, Sauvé S.

Chem Cent J. 2008 Jul 2;2:14.PMID: 18597692 [PubMed]Free PMC ArticleFree textRelated citations

Recent advances in understanding the biomolecular basis of chronic beryllium disease: a review.

McCleskey TM, Buchner V, Field RW, Scott BL.

Rev Environ Health. 2009 Apr-Jun;24(2):75-115. Review.PMID: 19658317 [PubMed - indexed for MEDLINE]Related citations

Determination of beryllium and selenium in human urine and of selenium in human serum by graphite-furnace atomic absorption spectrophotometry.

Wang HC, Peng HW, Kuo MS.

Anal Sci. 2001 Apr;17(4):527-32.PMID: 11990571 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Electrostatic potential on human leukocyte antigen: implications for putative mechanism of chronic beryllium disease.

Snyder JA, Weston A, Tinkle SS, Demchuk E.

Environ Health Perspect. 2003 Nov;111(15):1827-34. Review.PMID: 14630515 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Measurement of beryllium in lung tissue of a chronic beryllium disease case and cases with sarcoidosis.

Verma DK, Ritchie AC, Shaw ML.

Occup Med (Lond). 2003 May;53(3):223-7.PMID: 12724557 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Influence of chelating agents on the toxicity and distribution of beryllium in rats.

Shukla S, Sharma P, Johri S, Mathur R.

J Appl Toxicol. 1998 Sep-Oct;18(5):331-5.PMID: 9804433 [PubMed - indexed for MEDLINE]Related citations

Human leukocyte antigen Class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity.

Rossman MD, Stubbs J, Lee CW, Argyris E, Magira E, Monos D.

Am J Respir Crit Care Med. 2002 Mar 15;165(6):788-94.PMID: 11897645 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Impact of negatively charged patches on the surface of MHC class II antigen-presenting proteins on risk of chronic beryllium disease.

Snyder JA, Demchuk E, McCanlies EC, Schuler CR, Kreiss K, Andrew ME, Frye BL, Ensey JS, Stanton ML, Weston A.

J R Soc Interface. 2008 Jul 6;5(24):749-58.PMID: 17956852 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease.

Maier LA, McGrath DS, Sato H, Lympany P, Welsh K, Du Bois R, Silveira L, Fontenot AP, Sawyer RT, Wilcox E, Newman LS.

J Immunol. 2003 Dec 15;171(12):6910-8.PMID: 14662898 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Is total mass or mass of alveolar-deposited airborne particles of beryllium a better predictor of the prevalence of disease? A preliminary study of a beryllium processing facility.

Kent MS, Robins TG, Madl AK.

Appl Occup Environ Hyg. 2001 May;16(5):539-58.PMID: 11370934 [PubMed - indexed for MEDLINE]Related citations

Flow injection determination of Pb and Cd traces with graphite furnace atomic absorption spectrometry.

Colognesi M, Abollino O, Aceto M, Sarzanini C, Mentasti E.

Talanta. 1997 May;44(5):867-75.PMID: 18966814 [PubMed - in process]Related citations

[Determination of beryllium in atmospheric particulate by graphite furnace atomic absorption spectrophotometer using aluminium as a matrix modifier agent sampling with micropore filter membrane]

Wang Z, Zhu W, Lu Y.

Guang Pu Xue Yu Guang Pu Fen Xi. 2001 Aug;21(4):545-7. Chinese. PMID: 12945289 [PubMed - indexed for MEDLINE]Related citations

Beryllium presentation to CD4+ T cells is dependent on a single amino acid residue of the MHC class II beta-chain.

Bill JR, Mack DG, Falta MT, Maier LA, Sullivan AK, Joslin FG, Martin AK, Freed BM, Kotzin BL, Fontenot AP.

J Immunol. 2005 Nov 15;175(10):7029-37.PMID: 16272364 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Sensitive method for nontransferrin-bound iron quantification by graphite furnace atomic absorption spectrometry.

Jakeman A, Thompson T, McHattie J, Lehotay DC.

Clin Biochem. 2001 Feb;34(1):43-7.PMID: 11239514 [PubMed - indexed for MEDLINE]Related citations

Potential binding modes of beryllium with the class II major histocompatibility complex HLA-DP: a combined theoretical and structural database study.

Scott BL, Wang Z, Marrone BL, Sauer NN.

J Inorg Biochem. 2003 Feb 1;94(1-2):5-13.PMID: 12620668 [PubMed - indexed for MEDLINE]Related citations

HLA-DPB1 glutamate 69: a genetic marker of beryllium disease.

Richeldi L, Sorrentino R, Saltini C.

Science. 1993 Oct 8;262(5131):242-4.PMID: 8105536 [PubMed - indexed for MEDLINE]Related citations

Genetic determinants of sensitivity to beryllium in mice.

Tarantino-Hutchison LM, Sorrentino C, Nadas A, Zhu Y, Rubin EM, Tinkle SS, Weston A, Gordon T.

J Immunotoxicol. 2009 Jun;6(2):130-5.PMID: 19589099 [PubMed - indexed for MEDLINE]Related citations

HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease.

Lombardi G, Germain C, Uren J, Fiorillo MT, du Bois RM, Jones-Williams W, Saltini C, Sorrentino R, Lechler R.

J Immunol. 2001 Mar 1;166(5):3549-55.PMID: 11207315 [PubMed - indexed for MEDLINE]Free ArticleRelated citations